Levine J D, Fields H L, Basbaum A I
Department of Medicine, University of California, San Francisco 94143.
J Neurosci. 1993 Jun;13(6):2273-86. doi: 10.1523/JNEUROSCI.13-06-02273.1993.
An expanding knowledge of neuropeptides and their function has led to a profound change in our view of how the PAN contributes to pain. In addition to their expected direct action on postsynaptic cells in the dorsal horn, neuropeptides can modify transmitter release from nearby terminals of other PANs and/or diffuse to act on dorsal horn neurons at a considerable distance from their site of release (Fig. 2). Contrary to early expectations and despite the evidence that several neuropeptides excite central nociceptive neurons, there is no clear correspondence between neuropeptide content and physiologically defined classes of small-diameter primary afferents. There is, however, a tendency for populations of afferents innervating different organs to differ consistently in their peptide content. In fact, the peptide content of primary afferents is, in part, determined by specific factors in the tissues that they innervate. Furthermore, peptide content can change dramatically in response to certain prolonged stimuli or nerve damage. The lack of correspondence of peptide content and physiological response pattern, the plasticity of peptide content, its tissue specificity, and the possibility for action at a distance from the site of their release from central PAN terminals strongly suggest that PAN peptides have functions that are fundamentally different from those of the short-range actions of amino acid neurotransmitters that are also found in the PAN. Finally, nowhere is the plasticity of function of the PAN more evident than at its peripheral terminals. Long-term changes are produced in these terminals by a host of peptides that derive from a variety of cell types. The complexity of this transduction process is augmented by the activity-induced release of peripherally active neuropeptides from the PAN itself. In addition to the variety of fundamental neurobiological issues that recent studies of PANs have raised, they have also generated a great deal of clinical interest, in view of the role of the PAN in inflammation and its accessibility for study and for therapeutic intervention.
对神经肽及其功能的认识不断扩展,使我们对初级感觉传入神经元(PAN)如何导致疼痛的看法发生了深刻变化。除了预期它们对背角突触后细胞有直接作用外,神经肽还可以改变来自其他PAN附近终末的递质释放,和/或扩散到距其释放部位相当远的距离作用于背角神经元(图2)。与早期的预期相反,尽管有证据表明几种神经肽能兴奋中枢伤害性神经元,但神经肽含量与生理上定义的小直径初级传入神经类别之间并没有明确的对应关系。然而,支配不同器官的传入神经群体在其肽含量上往往存在一致的差异。事实上,初级传入神经的肽含量部分由它们所支配组织中的特定因素决定。此外,肽含量可因某些长时间刺激或神经损伤而发生显著变化。肽含量与生理反应模式缺乏对应关系、肽含量的可塑性、其组织特异性以及从中央PAN终末释放部位远距离起作用的可能性,都强烈表明PAN肽具有与PAN中也存在的氨基酸神经递质的短程作用根本不同的功能。最后,PAN功能的可塑性在其外周终末最为明显。许多来自各种细胞类型的肽在这些终末产生长期变化。PAN自身活性诱导释放外周活性神经肽,增加了这种转导过程的复杂性。除了最近对PAN的研究所提出的各种基本神经生物学问题外,鉴于PAN在炎症中的作用及其在研究和治疗干预方面的可及性,它们也引起了极大的临床兴趣。